Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity

This publication has 28 references indexed in Scilit:

• Tumor necrosis factor-alpha in isolated perfusion systems in the treatment of cancer: The Rotterdam Preclinical-Clinical Program
  Seminars in Surgical Oncology, 1998
• Isolated limb perfusion with TNFα and melphalan in a rat osteosarcoma model: a new anti-tumour approach
  European Journal of Surgical Oncology, 1996
• Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat
  British Journal of Surgery, 1996
• Neoadjuvant Chemotherapy for Osteosarcoma of the Extremity
  Published by Wolters Kluwer Health ,1987
• Role of Hyperthermic Perfusion in the Treatment of Limb Osteogenic Sarcoma
  Oncology, 1987
• Modulation of endothelial cell hemostatic properties by tumor necrosis factor.
  The Journal of Experimental Medicine, 1986
• Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro
  Science, 1985
• Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
  International Journal of Cancer, 1984
• Osteosarcoma: Intra-arterial treatment of the primary tumor with cis-diammine-dichloroplatinum II (CDP): Angiographic, pathologic, and pharmacologic studies
  Cancer, 1983
• Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions
  European Journal of Cancer and Clinical Oncology, 1982